Live webinar: Are cell and gene therapies dangerous goods?

Date: February 29, 2024
Time: 2:00pm CET
Duration: 45 minutes

Following the resounding success of last year's webinar, which tackled the frequent misclassification of cell and gene therapies as dangerous goods and received overwhelmingly positive feedback, we're excited to offer a sequel. This year, we aim to probe deeper into the categorization of cell and gene therapies as genetically modified organisms and infectious substances.

This forthcoming webinar offers attendees a comprehensive overview of dangerous goods classifications. Our speakers will examine these regulations in the context of cell and gene therapies, exploring their implications for logistics operations. In addition, they'll provide an outline of pertinent guidelines along with relevant case studies. Don't miss this chance to build on the insights from our well-attended previous session as we continue to illuminate this vital aspect of our industry.

Attendees too are warmly welcomed to bring the challenges they are facing relating to dangerous good classifications for discussion and no-nonsense answers.